OXB — Oxford BioMedica Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Oxford BioMedica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	109	141	104	60.6	96.9
Net Total Accounts Receivable
Net Total Receivables	42.1	57.6	20.4	55	65.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	164	216	141	133	186
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	69.7	134	75.7	64.3	108
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets	237	460	252	232	326
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33.3	59.7	44.3	58.3	84.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	49.9	256	178	175	234
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	187	205	74	57	91.3
Total Liabilities & Shareholders' Equity	237	460	252	232	326
Total Common Shares Outstanding